Clinical Trials in Matsumoto, Japan
3 recruiting
Showing 1–17 of 17 trials
Recruiting
Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Hematological Malignancies
Janssen Research & Development, LLC510 enrolled78 locationsNCT04634552
Recruiting
Phase 3
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Colitis UlcerativeArthritis, PsoriaticCrohns Disease+1 more
Janssen Research & Development, LLC196 enrolled42 locationsNCT06663332
Recruiting
Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Primary IgA Nephropathy
Novartis Pharmaceuticals540 enrolled161 locationsNCT04557462
Recruiting
Phase 3
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-small Cell Lung Cancer
Summit Therapeutics1,600 enrolled253 locationsNCT05899608
Recruiting
Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Novo Nordisk A/S1,280 enrolled289 locationsNCT07207811
Recruiting
Phase 3
Study of Out of Specification for Tisagenlecleucel
Diffuse Large B Cell LymphomaB-cell Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals200 enrolled53 locationsNCT04094311
Recruiting
Specified Drug-use Surveillance of Fabhalta Capsules
Paroxysmal nocturnal hemoglobinuria
Novartis Pharmaceuticals100 enrolled92 locationsNCT06606314
Recruiting
Phase 1Phase 2
A Study of TRK-950 in Patients With Advanced Solid Tumors
MelanomaSolid Tumor
Toray Industries, Inc49 enrolled10 locationsNCT05423262
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia
Schizophrenia
Bristol-Myers Squibb250 enrolled55 locationsNCT06882785
Recruiting
Revolade Tablets Specified Drug-use Survey
Aplastic Anemia
Novartis Pharmaceuticals10 enrolled17 locationsNCT06287268
Recruiting
Not Applicable
Pilot Study: Effects of CCP Intervention on NICU Environment and Preterm Infants Development
Preterm Infant HealthPreterm Infant Development
Turku University Hospital100 enrolled3 locationsNCT07306000
Recruiting
Special Drug Use-results Surveillance of Tafinlar/Mekinist
BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor
Novartis Pharmaceuticals110 enrolled68 locationsNCT06262919
Recruiting
Not Applicable
Isolated Surgical Aortic Valve Replacement in Low Risk AS Patients
Aortic Stenosis
Osaka University800 enrolled37 locationsNCT06924151
Recruiting
Japanese Coronary Intervention Using Drug Eluting and Perfusion Therapy for Left Main Disease (JDEPTH-LM Registry)
Non ST elevation acute coronary syndromeStable AnginaUnstable Angina
TCROSS Co., Ltd.280 enrolled32 locationsNCT06436092
Recruiting
Phase 2
Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)
MetforminT2DM (Type 2 Diabetes Mellitus)SGLT2-Inhibitors
Shinshu University120 enrolled1 locationNCT05469659
Recruiting
Phase 2
Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients
Osteoporosis
Shinshu University90 enrolled1 locationNCT03755193
Recruiting
Not Applicable
Non-weight Bearing in Hip Joint With Accompanying Joint Pain Might Not Progress Radiographic OA
Hip OA
Shinshu University100 enrolled1 locationNCT02329093